ExodusPoint Capital Management’s RxSight RXST Stock Holding History

ExodusPoint Capital Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$657K	Buy	106,638 +15,716	+17%	+$131K	0.01%	1118
2025 Q4	$947K	Buy	90,922 +23,500	+35%	+$236K	0.01%	1017
2025 Q3	$606K	Buy	+67,422	New	+$592K	0.01%	1129
2025 Q2	–	Sell	-15,944	Closed	-$403K	–	1911
2025 Q1	$403K	Sell	15,944 -8,473	-35%	-$252K	﹤0.01%	1159
2024 Q4	$839K	Buy	24,417 +6,534	+37%	+$295K	0.01%	1000
2024 Q3	$884K	Buy	+17,883	New	+$916K	0.01%	1007
2024 Q2	–	Sell	-11,114	Closed	-$573K	–	1924
2024 Q1	$573K	Buy	+11,114	New	+$546K	﹤0.01%	1109

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ExodusPoint Capital Management's RXST Position: Q1 2026 in Review

ExodusPoint Capital Management increased its RxSight (RXST) stake by 17% in Q1 2026, buying an estimated $131K and bringing the position to 106,638 shares worth $657K. The position accounts for 0.01% of the portfolio, ranked #1118.

ExodusPoint Capital Management first reported a position in RXST in Q1 2024 and has held it in 7 quarters since. The position peaked at $947K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

ExodusPoint Capital Management held 106,638 shares of RxSight worth $657K as of Q1 2026.
ExodusPoint Capital Management bought 15,716 RxSight shares in Q1 2026, an estimated $131K.
RxSight made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1118 holding.
ExodusPoint Capital Management first reported a position in RxSight in Q1 2024 and has held it in 7 quarters since.
ExodusPoint Capital Management's RxSight position peaked at $947K in Q4 2025.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.